Found: 2
Select item for more details and to access through your institution.
Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double‐blind study in healthy adults.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 6, p. 643, doi. 10.1111/head.14731
- By:
- Publication type:
- Article
The burden of disease in pyruvate kinase deficiency: Patients' perception of the impact on health‐related quality of life.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 6, p. 758, doi. 10.1111/ejh.13128
- By:
- Publication type:
- Article